0001801266-20-000001.txt : 20200205 0001801266-20-000001.hdr.sgml : 20200205 20200205170001 ACCESSION NUMBER: 0001801266-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 EFFECTIVENESS DATE: 20200205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rgenta Therapeutics, Inc. CENTRAL INDEX KEY: 0001801266 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-359879 FILM NUMBER: 20579571 BUSINESS ADDRESS: STREET 1: 15 LINCOLN ROAD CITY: BROOKLINE STATE: MA ZIP: 02445 BUSINESS PHONE: 781-608-3996 MAIL ADDRESS: STREET 1: 15 LINCOLN ROAD CITY: BROOKLINE STATE: MA ZIP: 02445 D 1 primary_doc.xml X0708 D LIVE 0001801266 Rgenta Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 781-608-3996 DELAWARE None None Corporation true 2019 Hualin Simon Xi c/o Rgenta Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Zhiping Weng c/o Rgenta Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Martin Heidecker c/o Rgenta Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Sun Linghao c/o Rgenta Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Travis Wager c/o Rgenta Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Other Decline to Disclose 06b false 2020-01-21 false true false 0 19999573 5999917 13999656 false 4 0 0 0 false Rgenta Therapeutics, Inc. /s/ Hualin S. Xi Hualin S. Xi Chief Executive Officer 2020-02-05